PL2598531T3 - Sposoby i kompozycje do terapii nowotworu wątroby - Google Patents
Sposoby i kompozycje do terapii nowotworu wątrobyInfo
- Publication number
- PL2598531T3 PL2598531T3 PL11738200T PL11738200T PL2598531T3 PL 2598531 T3 PL2598531 T3 PL 2598531T3 PL 11738200 T PL11738200 T PL 11738200T PL 11738200 T PL11738200 T PL 11738200T PL 2598531 T3 PL2598531 T3 PL 2598531T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- treatment
- methods
- liver cancer
- liver
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/595—Gastrins; Cholecystokinins [CCK]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36785110P | 2010-07-26 | 2010-07-26 | |
| US201161476204P | 2011-04-15 | 2011-04-15 | |
| PCT/EP2011/062686 WO2012013609A1 (en) | 2010-07-26 | 2011-07-22 | Methods and compositions for liver cancer therapy |
| EP11738200.2A EP2598531B1 (en) | 2010-07-26 | 2011-07-22 | Methods and compositions for liver cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2598531T3 true PL2598531T3 (pl) | 2021-08-30 |
Family
ID=45493809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11738200T PL2598531T3 (pl) | 2010-07-26 | 2011-07-22 | Sposoby i kompozycje do terapii nowotworu wątroby |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10533050B2 (pl) |
| EP (1) | EP2598531B1 (pl) |
| JP (1) | JP5726305B2 (pl) |
| KR (1) | KR101576174B1 (pl) |
| CN (1) | CN103261224B (pl) |
| AR (1) | AR082340A1 (pl) |
| AU (1) | AU2011284908B2 (pl) |
| BR (1) | BR112013002012A2 (pl) |
| CA (1) | CA2806157C (pl) |
| EA (2) | EA028515B1 (pl) |
| ES (1) | ES2871092T3 (pl) |
| NZ (1) | NZ606195A (pl) |
| PL (1) | PL2598531T3 (pl) |
| SG (2) | SG10201703556YA (pl) |
| WO (1) | WO2012013609A1 (pl) |
| ZA (1) | ZA201300567B (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0911925B8 (pt) | 2008-08-05 | 2024-02-06 | Toray Industries | Método para detectar um câncer |
| PT2322221E (pt) | 2008-08-05 | 2014-09-19 | Toray Industries | Composição farmacêutica para tratamento e prevenção de cancro |
| AU2010306119A1 (en) * | 2009-10-16 | 2012-05-03 | Centre National De La Recherche Scientifique (Cnrs) | Monoclonal antibodies to progastrin and their uses |
| US8900817B2 (en) * | 2010-01-08 | 2014-12-02 | Les Laboratories Servier | Progastrin and liver pathologies |
| KR101805520B1 (ko) | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| ES2634249T3 (es) | 2011-08-04 | 2017-09-27 | Toray Industries, Inc. | Composición farmacéutica para el tratamiento y/o la profilaxis del cáncer |
| WO2013018886A1 (ja) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | 膵臓癌の治療及び／又は予防用医薬組成物 |
| PT2741085T (pt) | 2011-08-04 | 2017-06-30 | Toray Industries | Método para a deteção de cancro prancreático |
| EP2818483B1 (en) | 2012-02-21 | 2017-08-02 | Toray Industries, Inc. | Medicinal composition for treating and/or preventing cancer |
| CA2864999C (en) | 2012-02-21 | 2020-06-30 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| US9273130B2 (en) | 2012-02-21 | 2016-03-01 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| MX360211B (es) | 2012-02-21 | 2018-10-24 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. |
| CA2869123C (en) | 2012-03-30 | 2021-03-16 | Toray Industries, Inc. | Pharmaceutical composition comprising anti-caprin-1 antibodies for the treatment of gallbladder cancer |
| CN104220095B (zh) * | 2012-03-30 | 2016-09-07 | 东丽株式会社 | 肝癌的治疗和/或预防用药物组合物 |
| PL2876447T3 (pl) | 2012-07-19 | 2020-05-18 | Toray Industries, Inc. | Sposób wykrywania nowotworu |
| EP2876446B1 (en) | 2012-07-19 | 2018-12-26 | Toray Industries, Inc. | Method for detecting cancer |
| EP3031826B1 (en) | 2013-08-09 | 2018-10-10 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| JP6951971B2 (ja) * | 2014-09-10 | 2021-10-20 | ダブル ボンド ファーマシューティカル アクチボラグ | 親水性薬物の標的化された送達 |
| EP3023884A1 (en) * | 2014-11-21 | 2016-05-25 | Thomson Licensing | Method and apparatus for generating fingerprint of an audio signal |
| CN114705858A (zh) | 2015-12-31 | 2022-07-05 | Syncerus有限责任公司 | 用于评估癌症发生的风险的组合物和方法 |
| SG11201805263TA (en) | 2015-12-31 | 2018-07-30 | Progastrine Et Cancers S A R L | Compositions and methods for detecting and treating esophageal cancer |
| ES2901602T3 (es) | 2015-12-31 | 2022-03-23 | Progastrine Et Cancers S A R L | Composiciones y métodos para detectar y tratar el cáncer ovárico |
| EP3954998B1 (en) | 2015-12-31 | 2024-12-25 | ECS-Progastrin SA | Compositions and methods for detecting and treating gastric cancer |
| KR102616819B1 (ko) | 2017-03-30 | 2023-12-21 | 프로가스트린 에 캔서스 에스.에이 알.엘. | 폐암을 치료하기 위한 조성물 및 방법 |
| WO2018178352A1 (en) | 2017-03-30 | 2018-10-04 | Progastrine Et Cancers S.À R.L. | Compositions and methods for detecting prostate cancer |
| US11046758B2 (en) * | 2017-12-05 | 2021-06-29 | Progastrine Et Cancers S.À R.L. | Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer |
| SG11202005332WA (en) | 2017-12-08 | 2020-07-29 | Ecs Biotracker Sarl | Radiolabeled progastrin in cancer diagnosis |
| TW201940881A (zh) | 2018-01-26 | 2019-10-16 | 瑞士商Ｅｃｓ前胃泌激素公司 | 在癌症診斷中結合前胃泌激素檢測與其他癌症生物標記的技術 |
| EP3759492A1 (en) | 2018-02-27 | 2021-01-06 | ECS-Progastrin SA | Progastrin as a biomarker for immunotherapy |
| AU2020358101A1 (en) * | 2019-10-02 | 2022-04-28 | Alamab Therapeutics, Inc. | Anto-connexin antibody formulations |
| AU2024322975A1 (en) * | 2023-08-04 | 2026-03-05 | Fortvita Biologics Inc. | Anti-ox40l antibody and use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| PT1077721E (pt) * | 1998-05-15 | 2007-06-21 | Receptor Biologix Inc | Prevenção e tratamento da hipergastrinemia. |
| KR20040049830A (ko) * | 2001-07-09 | 2004-06-12 | 애프톤 코포레이션 | 간, 폐 및 식도의 암 및 전암 상태의 치료 및 예방 |
| US20080057519A1 (en) * | 2003-06-02 | 2008-03-06 | Mcwhirter John | Cell Surface Protein Associated with Human Chronic Lymphocytic Leukemia |
| JP2008513536A (ja) * | 2004-09-22 | 2008-05-01 | レセプター バイオロジックス インコーポレイテッド | プロガストリンに対するモノクローナル抗体 |
| AU2007252986B2 (en) * | 2006-05-22 | 2013-03-21 | Centre National De La Recherche Scientifique - Cnrs- | Progastrin inhibitors in the treatment of colon cancer |
| US7854932B2 (en) * | 2006-12-19 | 2010-12-21 | The Board Of Regents Of The University Of Texas System | Immunogenic compositions comprising progastrin and uses thereof |
| AU2010306119A1 (en) * | 2009-10-16 | 2012-05-03 | Centre National De La Recherche Scientifique (Cnrs) | Monoclonal antibodies to progastrin and their uses |
| US9217032B2 (en) * | 2010-01-08 | 2015-12-22 | Les Laboratoires Servier | Methods for treating colorectal cancer |
| US8900817B2 (en) * | 2010-01-08 | 2014-12-02 | Les Laboratories Servier | Progastrin and liver pathologies |
| US9487582B2 (en) * | 2010-01-08 | 2016-11-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods for treating pancreatic cancer |
| AU2011231978B2 (en) * | 2010-03-24 | 2014-12-18 | Centre National De La Recherche Scientifique (Cnrs) | Prophylaxis of colorectal and gastrointestinal cancer |
-
2011
- 2011-07-22 CN CN201180046160.4A patent/CN103261224B/zh not_active Expired - Fee Related
- 2011-07-22 NZ NZ606195A patent/NZ606195A/en not_active IP Right Cessation
- 2011-07-22 KR KR1020137004701A patent/KR101576174B1/ko not_active Expired - Fee Related
- 2011-07-22 SG SG10201703556YA patent/SG10201703556YA/en unknown
- 2011-07-22 SG SG2013003512A patent/SG187544A1/en unknown
- 2011-07-22 ES ES11738200T patent/ES2871092T3/es active Active
- 2011-07-22 AU AU2011284908A patent/AU2011284908B2/en not_active Ceased
- 2011-07-22 EA EA201300171A patent/EA028515B1/ru not_active IP Right Cessation
- 2011-07-22 PL PL11738200T patent/PL2598531T3/pl unknown
- 2011-07-22 WO PCT/EP2011/062686 patent/WO2012013609A1/en not_active Ceased
- 2011-07-22 EA EA201790882A patent/EA201790882A1/ru unknown
- 2011-07-22 EP EP11738200.2A patent/EP2598531B1/en active Active
- 2011-07-22 CA CA2806157A patent/CA2806157C/en not_active Expired - Fee Related
- 2011-07-22 US US13/189,403 patent/US10533050B2/en not_active Expired - Fee Related
- 2011-07-22 BR BR112013002012-1A patent/BR112013002012A2/pt not_active Application Discontinuation
- 2011-07-22 JP JP2013521088A patent/JP5726305B2/ja not_active Expired - Fee Related
- 2011-07-25 AR ARP110102679A patent/AR082340A1/es unknown
-
2013
- 2013-01-22 ZA ZA2013/00567A patent/ZA201300567B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013533277A (ja) | 2013-08-22 |
| EA201300171A1 (ru) | 2013-07-30 |
| EP2598531B1 (en) | 2020-12-30 |
| ZA201300567B (en) | 2014-03-26 |
| EP2598531A1 (en) | 2013-06-05 |
| AU2011284908B2 (en) | 2015-05-21 |
| US20120020961A1 (en) | 2012-01-26 |
| KR101576174B1 (ko) | 2015-12-09 |
| EA028515B1 (ru) | 2017-11-30 |
| KR20130083438A (ko) | 2013-07-22 |
| CN103261224A (zh) | 2013-08-21 |
| SG10201703556YA (en) | 2017-06-29 |
| WO2012013609A1 (en) | 2012-02-02 |
| CA2806157C (en) | 2016-11-22 |
| CA2806157A1 (en) | 2012-02-02 |
| AR082340A1 (es) | 2012-11-28 |
| JP5726305B2 (ja) | 2015-05-27 |
| SG187544A1 (en) | 2013-03-28 |
| ES2871092T3 (es) | 2021-10-28 |
| CN103261224B (zh) | 2015-10-07 |
| AU2011284908A1 (en) | 2013-02-07 |
| US10533050B2 (en) | 2020-01-14 |
| BR112013002012A2 (pt) | 2019-08-27 |
| NZ606195A (en) | 2015-02-27 |
| EA201790882A1 (ru) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2598531T3 (pl) | Sposoby i kompozycje do terapii nowotworu wątroby | |
| PL3443957T3 (pl) | Związki i kompozycje stosowane w leczeniu nowotworów | |
| PL2552438T3 (pl) | Sposoby leczenia raka wątrobowokomórkowego | |
| EP2877159B8 (en) | Efflux inhibitor compositions and methods of treatment using the same | |
| IL225471A0 (en) | Preparations and methods for the prevention and treatment of cancer | |
| PL3023788T3 (pl) | Kompozycje neoantygenów specyficznych wobec nowotworu do zastosowania w leczeniu nowotworów | |
| HUE039506T2 (hu) | Ibat inhibitorok májbetegségek kezelésére | |
| BR112014001440A2 (pt) | novas composições e métodos para o tratamento de câncer de próstata | |
| HUE042535T2 (hu) | Szerves vegyület a májrák kezelésére | |
| PL3199024T3 (pl) | Zastosowanie kompozycji cyklodekstryny i stosowne sposoby | |
| IL225262A0 (en) | Methods and compositions for treating lung cancer | |
| ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento | |
| IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
| PL2830654T3 (pl) | Sposoby i kompozycje do leczenia zapalenia | |
| IL220386B (en) | Compositions for the liquidation of tumors and uses thereof | |
| SG10201500124VA (en) | Methods and Compositions for Treating Cancer | |
| EP2526118A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF EGG CANCER | |
| IL226246A0 (en) | Methods of treating cancer | |
| PL2605764T3 (pl) | Kompozycje do leczenia nowotworu | |
| PL2718434T3 (pl) | Kompozycje i sposoby leczenia choroby trzewnej | |
| IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
| IL231907B (en) | Compounds and compositions for treatment of transthyretin-associated amyloidosis | |
| PL2632475T3 (pl) | Kompozycje do leczenia wrzodów peryferyjnych o zróżnicowanym pochodzeniu | |
| BR112013028890A2 (pt) | composições e métodos para o tratamento de câncer | |
| WO2012003421A9 (en) | Combinational compositions and methods for treatment of cancer |